Hubert C Chen's Net Worth
$656 Thousand
Who is Hubert C Chen?
Hubert C Chen does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Forte Biosciences, Inc., Metacrine, Inc., and Pfenex Inc..
SEC CIK
Hubert C Chen's CIK is 0001622297
Past Insider Trading and Trends
2023 was Hubert C Chen's most active year for acquiring shares with 5 total transactions. Hubert C Chen's most active month to acquire stocks was the month of January. 2023 was Hubert C Chen's most active year for disposing of shares, totalling 6 transactions. Hubert C Chen's most active month to dispose stocks was the month of December. 2023 saw Hubert C Chen paying a total of $74,999.57 for 216,757 shares, this is the most they've acquired in one year. In 2023 Hubert C Chen cashed out on 30,279 shares for a total of $7,032.22, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Forte Biosciences, Inc. (FBRX) Snapshot price: $7.85
See remarksHubert C Chen owns 93,405 units of Common Stock which is worth $733,229.25. In the year 2023 Hubert C Chen acquired a total of 104,257 shares in Forte Biosciences, Inc. at a cost of $74,999.57, Hubert also disposed a total of 10,852 shares of Forte Biosciences, Inc. equalling to $9,557.30.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.98% | 4.43K |
$0.82 | -$2,525.08 | 93.41K |
Jan 1
| |||
Form 4
| +5.84% | 4.91K |
$0.66 | -$1,716.57 | 88.98K |
Oct 1
| |||
Form 4
| +756.64% | 74.26K |
$1.01 | $74,999.57 | 84.07K |
Jul 31
| |||
Form 4
| +100.00% | 4.91K |
$1.04 | -$2,696.72 | 9.81K |
Jul 1
| |||
Form 4
|
∞
| 4.91K |
$1.01 | -$2,618.93 | 4.91K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Metacrine, Inc. No price found
Chief Medical OfficerHubert C Chen owns 3,289 units of Common Stock. In the year 2020 Hubert C Chen acquired a total of 3,289 shares in Metacrine, Inc. at a cost of $11,840.40.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.29K |
$3.60 | $11,840.40 | 3.29K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Pfenex Inc. No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |